Suchergebnisse - "Menter, Alan"

PubPharm (7)

1

Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior Biologics

enthalten in: Journal of drugs in dermatology : JDD | 2022

von Lebwohl, M. | Menter, A. | Lain, E. | +2

2

Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in Psoriasis

enthalten in: Journal of drugs in dermatology : JDD | 2020

von Green, L. | Weinberg, J. | Menter, A. | +3

3

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

enthalten in: American journal of clinical dermatology | 2019

von Lebwohl, M. | Blauvelt, A. | Menter, A. | +5

4

Anti-IL17 therapies for psoriasis

enthalten in: Expert opinion on biological therapy | 2019

von Silfvast-Kaiser, A. | Paek, S. | Menter, A.

5

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis

enthalten in: Immunotherapy | 2017

von Roostaeyan, O. | Kivelevitch, D. | Menter, A.

6

A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies

enthalten in: Expert opinion on investigational drugs | 2016

von Campa, M. | Menter, A.

7

Use of brodalumab for the treatment of psoriasis and psoriatic arthritis

enthalten in: Immunotherapy | 2015

von Kivelevitch, D. | Menter, A.

1
[1]